Terms: = Lung cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
80 results:
1. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in
Pillai R; LeBoeuf SE; Hao Y; New C; Blum JLE; Rashidfarrokhi A; Huang SM; Bahamon C; Wu WL; Karadal-Ferrena B; Herrera A; Ivanova E; Cross M; Bossowski JP; Ding H; Hayashi M; Rajalingam S; Karakousi T; Sayin VI; Khanna KM; Wong KK; Wild R; Tsirigos A; Poirier JT; Rudin CM; Davidson SM; Koralov SB; Papagiannakopoulos T
Sci Adv; 2024 Mar; 10(13):eadm9859. PubMed ID: 38536921
[TBL] [Abstract] [Full Text] [Related]
2. nrf2 promotes radiation resistance by cooperating with TOPBP1 to activate the ATR-CHK1 signaling pathway.
Sun X; Dong M; Li J; Sun Y; Gao Y; Wang Y; Du L; Liu Y; Ji K; He N; Wang J; Zhang M; Song H; Xu C; Liu Q
Theranostics; 2024; 14(2):681-698. PubMed ID: 38169561
[No Abstract] [Full Text] [Related]
3. An antioxidant feedforward cycle coordinated by linker histone variant H1.2 and nrf2 that drives nonsmall cell lung cancer progression.
Chen Y; Shi J; Wang X; Zhou L; Wang Q; Xie Y; Peng C; Kuang L; Yang D; Yang J; Yang C; Li X; Yuan Y; Zhou Y; Peng A; Zhang Y; Chen H; Liu X; Zheng L; Huang K; Li Y
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2306288120. PubMed ID: 37729198
[TBL] [Abstract] [Full Text] [Related]
4. The promoting effect and mechanism of nrf2 on cell metastasis in cervical cancer.
Zhang M; Hong X; Ma N; Wei Z; Ci X; Zhang S
J Transl Med; 2023 Jul; 21(1):433. PubMed ID: 37403143
[TBL] [Abstract] [Full Text] [Related]
5.
Lu J; Ding Y; Zhang W; Qi Y; Zhou J; Xu N; Zhang Y; Xie W
Cells; 2023 Apr; 12(9):. PubMed ID: 37174639
[TBL] [Abstract] [Full Text] [Related]
6. Investigating the functional role of SETD6 in lung adenocarcinoma.
Xu J; Zhou H; Luo Z; Chen J; Liu M
BMC Cancer; 2023 Jan; 23(1):18. PubMed ID: 36604642
[TBL] [Abstract] [Full Text] [Related]
7. Histone lysine methyltransferase SETDB2 suppresses nrf2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma.
Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B
Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353
[TBL] [Abstract] [Full Text] [Related]
8. Transcription factor nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
Zhang Z; Chen Q; Huang C; Rao D; Sang C; Zhu S; Gu L; Xie C; Tang Z; Xu X
Mol Carcinog; 2022 Dec; 61(12):1161-1176. PubMed ID: 36193777
[TBL] [Abstract] [Full Text] [Related]
9. [Progress of nrf2 Signaling Pathway in Promoting Proliferation
of Non-small Cell lung cancer].
Fang Y; Zou X; Hu S; Ji L
Zhongguo Fei Ai Za Zhi; 2022 Oct; 25(10):735-741. PubMed ID: 36167459
[TBL] [Abstract] [Full Text] [Related]
10. Survival Outcomes and Treatment Patterns in Patients With nfe2l2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database.
Wu Y; Yin Y; Crossland V; Vincent S; Paik PK; Lineberry N; Faller DV
Clin Lung Cancer; 2022 Sep; 23(6):487-497. PubMed ID: 35705448
[TBL] [Abstract] [Full Text] [Related]
11. TRIM22 inhibits osteosarcoma progression through destabilizing nrf2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract] [Full Text] [Related]
12. Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in lung Adenocarcinoma.
Zhao F; Tian H; Liu X; Guan Y; Zhu Y; Ren P; Zhang J; Dong Y; Fu L
Oxid Med Cell Longev; 2022; 2022():4102666. PubMed ID: 35633885
[TBL] [Abstract] [Full Text] [Related]
13. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-nrf2 signaling pathway.
Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B
Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896
[TBL] [Abstract] [Full Text] [Related]
14. nrf2 drives an oxidative stress response predictive of breast cancer.
Wolowczyk C; Neckmann U; Aure MR; Hall M; Johannessen B; Zhao S; Skotheim RI; Andersen SB; Zwiggelaar R; Steigedal TS; Lingjærde OC; Sahlberg KK; Almaas E; Bjørkøy G
Free Radic Biol Med; 2022 May; 184():170-184. PubMed ID: 35381325
[TBL] [Abstract] [Full Text] [Related]
15. cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines.
Cheng X; Liu Y; Wang J; Chen Y; Robertson AG; Zhang X; Jones SJM; Taubert S
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35368077
[TBL] [Abstract] [Full Text] [Related]
16. Machine Learning Identifies Pan-cancer Landscape of nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
17. CHML is an nrf2 target gene that regulates mTOR function.
Dodson M; Dai W; Anandhan A; Schmidlin CJ; Liu P; Wilson NC; Wei Y; Kitamura N; Galligan JJ; Ooi A; Chapman E; Zhang DD
Mol Oncol; 2022 Apr; 16(8):1714-1727. PubMed ID: 35184380
[TBL] [Abstract] [Full Text] [Related]
18. HNMT Upregulation Induces cancer Stem Cell Formation and Confers Protection against Oxidative Stress through Interaction with HER2 in Non-Small-Cell lung cancer.
Kuo KT; Lin CH; Wang CH; Pikatan NW; Yadav VK; Fong IH; Yeh CT; Lee WH; Huang WC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163585
[TBL] [Abstract] [Full Text] [Related]
19. Thioredoxin reductase-1 levels are associated with nrf2 pathway activation and tumor recurrence in non-small cell lung cancer.
Delgobo M; Gonçalves RM; Delazeri MA; Falchetti M; Zandoná A; Nascimento das Neves R; Almeida K; Fagundes AC; Gelain DP; Fracasso JI; Macêdo GB; Priori L; Bassani N; Bishop AJR; Forcelini CM; Moreira JCF; Zanotto-Filho A
Free Radic Biol Med; 2021 Dec; 177():58-71. PubMed ID: 34673143
[TBL] [Abstract] [Full Text] [Related]
20. Cox15 is a novel oncogene that required for lung cancer cell proliferation.
Zhang C; Li N; Liu YY; Yuan T; Yang S; Wang XP
Biochem Biophys Res Commun; 2021 Nov; 578():70-76. PubMed ID: 34547626
[TBL] [Abstract] [Full Text] [Related]
[Next]
